Sugi Predict

Sugi Predict / Compounds / SCHEMBL15466532

SCHEMBL15466532

SCHEMBL15466532

Nc1cccc([C@@H]2C[C@H]3CCC[C@@H](C2)N3[C@@H]2C[C@@H]3CCCC[C@@H](C3)C2)c1N

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ OGFRL1 Q5TC84 19/20 0.38
▸ OPRL1 P41146 19/20 0.38
▸ OPRK1 P41145 6/20 0.38
▸ OPRM1 P35372 4/20 0.38
▸ OPRD1 P41143 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15842234 1.00 OGFRL1 (0.38) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL15466533 1.00 OGFRL1 (0.38) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL854188 0.99 OGFRL1 (0.39) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL854189 0.99 OGFRL1 (0.39) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL853521 0.96 OGFRL1 (0.36) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL853522 0.96 OGFRL1 (0.36) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL15845196 0.89 OPRM1 (0.37) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL854083 0.89 OPRM1 (0.37) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL15845198 0.89 OPRM1 (0.37) OGFRL1OPRL1OPRK1OPRM1OPRD1
SCHEMBL15847563 0.89 OPRM1 (0.37) OGFRL1OPRL1OPRK1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2880033-B1 CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA LP (US) 2020-06-17 — — EP disclosed
US-9598411-B2 Substituted benzimidazole-type piperidine compounds and uses thereof PURDUE PHARMA L.P. (US) 2017-03-21 — — US disclosed
US-20150322066-A1 SUBSTITUTED BENZIMIDAZOLE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF PURDUE PHARMA L.P. 2015-11-12 — — US disclosed
US-9090618-B2 Substituted benzimidazole-type piperidine compounds and uses thereof PURDUE PHARMA L.P. (US) 2015-07-28 — — US disclosed
US-9085561-B2 Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators PURDUE PHARMA L.P. (US) 2015-07-21 — — US disclosed
US-20140187535-A1 SUBSTITUTED BENZIMIDAZOLE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF SHIONOGI & CO., LTD. (JP) 2014-07-03 — — US disclosed
US-20140045830-A1 CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF SHIONOGI & CO., LTD. (JP) 2014-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140187535-A1 SUBSTITUTED BENZIMIDAZOLE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF H1-0, H1-3, CACNA1A OGFRL1 2889/4885OPRL1 181/4885OPRK1 27/4885
US-20140045830-A1 CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF QPCT, UBXN1, NQO2 OGFRL1 2320/4885OPRL1 68/4885OPRK1 16/4885
US-20150322066-A1 SUBSTITUTED BENZIMIDAZOLE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF H1-0, H1-3, CACNA1A OGFRL1 2889/4885OPRL1 181/4885OPRK1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.